首页> 美国卫生研究院文献>Neuro-Oncology >Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30 2014 Bethesda MD)
【2h】

Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30 2014 Bethesda MD)

机译:迅速启动的脑肿瘤药物开发联盟和FDA临床成像神经影像学终点研讨会的报告(2014年1月30日贝塞斯达医学博士)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

On January 30, 2014, a workshop was held on neuroimaging endpoints in high-grade glioma. This workshop was sponsored by the Jumpstarting Brain Tumor Drug Development Coalition, consisting of the National Brain Tumor Society, the Society for Neuro-Oncology, Accelerate Brain Cancer Cure, and the Musella Foundation for Research and Information, and conducted in collaboration with the Food and Drug Administration. The workshop included neuro-oncologists, neuroradiologists, radiation oncologists, neurosurgeons, biostatisticians, patient advocates, and representatives from industry, clinical research organizations, and the National Cancer Institute. This report summarizes the presentations and discussions of that workshop and the proposals that emerged to improve the Response Assessment in Neuro-Oncology (RANO) criteria and standardize neuroimaging parameters.
机译:2014年1月30日,举办了关于高级神经胶质瘤神经影像学终点的研讨会。该研讨会由全国脑肿瘤学会,神经肿瘤学会,加速脑癌治疗学会和Musella研究与信息基金会组成的Jumpstarting脑肿瘤药物开发联盟赞助,并与食品和药物管理局合作开展。药物管理。研讨会包括神经肿瘤学家,神经放射学家,放射肿瘤学家,神经外科医生,生物统计学家,患者拥护者,以及来自行业,临床研究组织和美国国家癌症研究所的代表。本报告总结了该研讨会的介绍和讨论,以及为改进神经肿瘤反应评估(RANO)标准和标准化神经成像参数而提出的建议。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号